We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Newborn baby lying on a blanket being examined by a healthcare professional.
Industry Insight

Shaping the Future of Newborn Screening

Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.
Hand holding a small wooden cube with a green tick, symbolizing verification, surrounded by vegetation.
Industry Insight

Funding Will Advance Third-Party Verified Sustainability in Science

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.
Transparent bubble containing a 3D DNA double helix strand on a light blue background.
Industry Insight

Bacteria-Based Technology Could Revolutionize Solid Tumor Treatment

At the BioTrinity 2025 conference, Technology Networks spoke with Dr. Pedro Correa de Sampaio, co-founder and CEO of Neobe, who are utilizing synthetic biology to engineer bacteria capable of breaking down the barriers within tumors.
Close-up of a test tube containing a DNA double helix, representing whole-genome sequencing.
Industry Insight

European Consortium Will Advance Long-Read Sequencing in Clinics

A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases and cancers.
Illustration of CAR T-cells attacking a cancer cell, representing immunotherapy in cancer treatment.
Industry Insight

Overcoming CAR T-Cell Therapy Limitations

In an interview with Arthur Stril, chief business officer and interim CFO at Cellectis, we explore how gene editing and innovative manufacturing strategies are overcoming the key limitations of autologous CAR T-cell therapy.
A pair of glasses and ball point pen laying on top of a folded newspaper with the headline "Research & Development".
Industry Insight

Why Good Science Is Key to Good Technology

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.
Illuminated ATGC letters in blue squares representing next-generation sequencing.
Industry Insight

How SPRQ Chemistry Is Breaking Barriers in DNA Sequencing

Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.
Abstract illustration of a human figure formed by glowing molecular structures and dynamic neural pathways, representing advancements in molecular biology.
Industry Insight

Breaking Down Barriers in Multiomic Imaging

Hear from an early user of the neofleXTM MALDI-TOF instrument about how the technology adds new capabilities to MSI workflows.
Gloved hand holding a test tube with liquid in front of a DNA double helix, symbolizing gene therapy research.
Industry Insight

The Rise of Cell and Gene Therapies in Treating Complex Diseases

Cell and gene therapies are revolutionizing medicine. Looking to 2025, advancements in allogeneic therapies, streamlined autologous processes and broader applications promise increased accessibility and innovation in treating complex diseases.
Group of people arranged in a DNA double helix pattern, representing the role of genomics in healthcare advancements
Industry Insight

Advancing Public Health With Genomic Insights

Technology Networks spoke with Dr. Mohamed Alameri to explore how population-wide genome initiatives are addressing gaps in genomic data representation and advancing precision medicine in areas such as rare diseases and cancer.
Advertisement